FFL
VRTX icon

Future Fund LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Future Fund LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.21M Buy
4,957
+154
+3% +$71.8K 0.78% 56
2025
Q4 		$2.18M Sell
4,803
-384
-7% -$166K 0.69% 42
2025
Q3 		$2.03M Buy
5,187
+1,184
+30% +$495K 0.72% 39
2025
Q2 		$1.78M Sell
4,003
-346
-8% -$159K 0.8% 30
2025
Q1 		$2.11M Buy
4,349
+2,297
+112% +$1.07M 2.71% 7
2024
Q4 		$826K Buy
2,052
+350
+21% +$162K 2.36% 22
2024
Q3 		$802K Sell
1,702
-482
-22% -$232K 2.32% 22
2024
Q2 		$1.03M Buy
2,184
+1,538
+238% +$668K 2.58% 18
2024
Q1 		$270K Sell
646
-314
-33% -$133K 2.19% 25
2023
Q4 		$391K Buy
+960
New +$355K 1.08% 10

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Future Fund LLC's VRTX Position: Q1 2026 in Review

Future Fund LLC increased its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q1 2026, buying an estimated $71.8K and bringing the position to 4,957 shares worth $2.21M. The position accounts for 0.78% of the portfolio, ranked #56.

Future Fund LLC first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Future Fund LLC held 4,957 shares of Vertex Pharmaceuticals worth $2.21M as of Q1 2026.
  • Future Fund LLC bought 154 Vertex Pharmaceuticals shares in Q1 2026, an estimated $71.8K.
  • Vertex Pharmaceuticals made up 0.78% of Future Fund LLC's portfolio in Q1 2026, its #56 holding.
  • Future Fund LLC first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Future Fund LLC's 13F filing for Q1 2026, filed 6 May 2026.